Skip to content

Dietary Salt Intake and Vascular Function

Dietary Salt Intake and Vascular Function

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00590512
Enrollment
133
Registered
2008-01-10
Start date
2005-03-31
Completion date
2012-11-30
Last updated
2013-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

dietary salt, sodium, blood vessels, vascular function, endothelial function, heart disease risk, cardiovascular disease risk

Brief summary

The purpose of this study is to look at the effects of high- and low-salt diets on blood vessel function in healthy subjects.

Detailed description

Healthy volunteers will be enrolled in a dietary sodium intervention to examine impact on vascular function.

Interventions

DIETARY_SUPPLEMENTHigh sodium
DIETARY_SUPPLEMENTLow sodium

Sponsors

Brigham and Women's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

1. Healthy male, African-American volunteers 2. 18-35 years of age, 3. No personal or first degree relative with hypertension or diabetes, 4. Blood pressure \<130/85 mmHg and \> 90/60 at the screening visit, 5. Body mass index \<30 kg/m2, 6. No clinically significant abnormalities on screening tests (complete blood count, serum electrolytes, liver enzymes, thyroid stimulating hormone, urinalysis and electrocardiogram).

Exclusion criteria

1. Alcohol intake \>2 beverage/night, 2. Smoking, 3. Recreational drug use, 4. Personal history of coronary disease, diabetes, hypertension, stroke, kidney disease, or illness requiring overnight hospitalization in the past 6 months, 5. Prescription or herbal medication use, 6. Ischemic changes on resting electrocardiogram, 7. Known hypersensitivity to any of the study drugs, 8. Other active medical problems detected by examination or laboratory testing.

Design outcomes

Primary

MeasureTime frame
endothelial functionone week

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026